09 May 2017 | News
. Medrobotics is the first and only company to offer minimally invasive, steerable and shapeable robotic products for colorectal procedures in the U.S.
Medrobotics has received FDA regulatory clearance to market the Flex® Robotic System for colorectal procedures in the United States. Medrobotics is the first and only company to offer minimally invasive, steerable and shapeable robotic products for colorectal procedures in the U.S.
The Flex® Robotic System is the world’s first robotic surgical platform to offer Scarfree™ access to hard-to-reach anatomy in otolaryngology and colorectal procedures. This provides surgeons treatment options that may not be possible with straight, rigid instruments.
The minimally invasive Flex® Robotic System offers surgeons the unique ability to navigate complex anatomy through a single, small entry point to operate in difficult-to-reach places.
Medrobotics is developing new surgical applications for its core platform technology in the areas of general surgery, gynecology, and urology, among others. These new applications are not yet cleared for use in the U.S.
The award-winning Flex® Robotic System has been widely recognized for advances in surgical robotic technology, including Best-in-Show at the 2016 Medical Design Excellence Awards (MDEA) and a Best New Product at the 2017 Edison Awards.